ACET logo

ACET
Adicet Bio Inc

3,737
Mkt Cap
$67.08M
Volume
64,016.00
52W High
$17.44
52W Low
$6.01
PE Ratio
-0.39
ACET Fundamentals
Price
$6.99
Prev Close
$6.88
Open
$6.81
50D MA
$7.29
Beta
1.04
Avg. Volume
110,724.66
EPS (Annual)
-$16.95
P/B
0.42
Rev/Employee
$0.00
$85.77
Loading...
Loading...
News
all
press releases
Adicet Bio, Inc. (NASDAQ:ACET) Given Average Rating of "Moderate Buy" by Analysts
Adicet Bio, Inc. (NASDAQ:ACET - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eight analysts that are covering the firm, Marketbeat reports. One analyst has...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
Adicet Bio (NASDAQ:ACET) Upgraded at Truist Financial
Truist Financial upgraded Adicet Bio to a "strong-buy" rating in a research report on Wednesday...
MarketBeat·9d ago
News Placeholder
Adicet Bio (ACET) Upgraded to Buy: Here's Why
Adicet Bio (ACET) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·11d ago
News Placeholder
Adicet Bio (NASDAQ:ACET) Price Target Cut to $27.00 by Analysts at HC Wainwright
HC Wainwright decreased their price target on Adicet Bio from $50.00 to $27.00 and set a "buy" rating on the stock in a research report on Monday...
MarketBeat·12d ago
News Placeholder
Guggenheim Issues Pessimistic Forecast for Adicet Bio (NASDAQ:ACET) Stock Price
Guggenheim cut their price target on Adicet Bio from $128.00 to $100.00 and set a "buy" rating for the company in a report on Friday...
MarketBeat·22d ago
News Placeholder
Adicet Bio (NASDAQ:ACET) Releases Earnings Results, Beats Expectations By $0.29 EPS
Adicet Bio (NASDAQ:ACET - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($2.94) earnings per share for the quarter, beating the consensus estimate of...
MarketBeat·23d ago
News Placeholder
Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today reported financial...
Business Wire·23d ago
News Placeholder
Adicet Bio (NASDAQ:ACET) Stock Passes Below 200 Day Moving Average - Here's What Happened
Adicet Bio (NASDAQ:ACET) Shares Pass Below Two Hundred Day Moving Average - Should You Sell...
MarketBeat·25d ago
News Placeholder
Adicet Bio, Inc. (NASDAQ:ACET) Given Average Rating of "Moderate Buy" by Brokerages
Shares of Adicet Bio, Inc. (NASDAQ:ACET - Get Free Report) have received an average recommendation of "Moderate Buy" from the seven research firms that are presently covering the company, MarketBeat...
MarketBeat·1mo ago
News Placeholder
Adicet Bio (ACET) Projected to Post Quarterly Earnings on Thursday
Adicet Bio (NASDAQ:ACET) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 5. (View Earnings Report at...
MarketBeat·1mo ago
<
1
2
...
>

Latest ACET News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.